ATE11529T1 - Parasubstituierte 3-phenoxy-1-alkylaminopropan-2- ole mit beta-rezeptor blockierenden eigenschaften. - Google Patents

Parasubstituierte 3-phenoxy-1-alkylaminopropan-2- ole mit beta-rezeptor blockierenden eigenschaften.

Info

Publication number
ATE11529T1
ATE11529T1 AT81850095T AT81850095T ATE11529T1 AT E11529 T1 ATE11529 T1 AT E11529T1 AT 81850095 T AT81850095 T AT 81850095T AT 81850095 T AT81850095 T AT 81850095T AT E11529 T1 ATE11529 T1 AT E11529T1
Authority
AT
Austria
Prior art keywords
alkylaminopropan
ols
phenoxy
para
substituted
Prior art date
Application number
AT81850095T
Other languages
English (en)
Inventor
Enar Ingemar Carlsson
Bill Benjamin Rudolf Gustafsson
Bo Torsten Lundgren
Original Assignee
Aktiebolaget Haessle
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktiebolaget Haessle filed Critical Aktiebolaget Haessle
Application granted granted Critical
Publication of ATE11529T1 publication Critical patent/ATE11529T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
AT81850095T 1980-06-02 1981-05-27 Parasubstituierte 3-phenoxy-1-alkylaminopropan-2- ole mit beta-rezeptor blockierenden eigenschaften. ATE11529T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8004087A SE8004087L (sv) 1980-06-02 1980-06-02 Nya parasubstituerade 3-fenoxi-1-alkylaminopropanol-2-er med betareceptorblockerande egenskaper, samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma, och metod att behandla akut ...
EP81850095A EP0041491B1 (de) 1980-06-02 1981-05-27 Parasubstituierte 3-Phenoxy-1-alkylaminopropan-2-ole mit beta-Rezeptor blockierenden Eigenschaften

Publications (1)

Publication Number Publication Date
ATE11529T1 true ATE11529T1 (de) 1985-02-15

Family

ID=20341101

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81850095T ATE11529T1 (de) 1980-06-02 1981-05-27 Parasubstituierte 3-phenoxy-1-alkylaminopropan-2- ole mit beta-rezeptor blockierenden eigenschaften.

Country Status (25)

Country Link
EP (1) EP0041491B1 (de)
JP (1) JPS5724335A (de)
KR (1) KR850000869B1 (de)
AT (1) ATE11529T1 (de)
AU (1) AU548290B2 (de)
CS (1) CS241484B2 (de)
DD (1) DD159328A5 (de)
DE (1) DE3168595D1 (de)
DK (1) DK154208C (de)
ES (1) ES502656A0 (de)
FI (1) FI71725C (de)
GR (1) GR74571B (de)
HU (1) HU184860B (de)
IE (1) IE53801B1 (de)
LU (2) LU88317I2 (de)
MY (1) MY8600219A (de)
NL (1) NL930102I2 (de)
NO (1) NO151282C (de)
NZ (1) NZ197237A (de)
PH (1) PH16135A (de)
PL (1) PL135823B1 (de)
PT (1) PT73111B (de)
SE (1) SE8004087L (de)
SU (1) SU1156592A3 (de)
ZA (1) ZA812981B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4593119A (en) * 1980-11-28 1986-06-03 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4578403A (en) * 1981-06-23 1986-03-25 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4455317A (en) * 1981-06-23 1984-06-19 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4454154A (en) * 1981-06-23 1984-06-12 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4559359A (en) * 1981-06-23 1985-12-17 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US5334601A (en) * 1984-03-14 1994-08-02 Bodor Nicholas S Soft β-adrenergic blocking agents
WO1985004168A1 (en) * 1984-03-14 1985-09-26 Bodor Nicholas S SOFT beta-ADRENERGIC BLOCKING AGENTS
US5135926A (en) * 1984-03-14 1992-08-04 Bodor Nicholas S Soft β-adrenergic blocking agents
US4829086A (en) * 1984-03-14 1989-05-09 Bodor Nicholas S Soft β-adrenergic blocking agents
US5202347A (en) * 1984-03-14 1993-04-13 Bodor Nicholas S Soft β-adrenergic blocking agents
AU575153B2 (en) * 1984-04-09 1988-07-21 Du Pont Merck Pharmaceutical Company, The Pharmaceutical compositions and method for treatment for prophylaxis of cardiac disorders
JP2521317B2 (ja) * 1986-09-02 1996-08-07 ザ・デュポン・メルク・ファーマシュウティカル・カンパニー ｄｌ―メチル３―［４―（２―ヒドロキシ―３―イソプロピルアミノ）プロポキシ］フエニルプロピオネ―ト［（ｄｌ―エスモロ―ル）］の分割
US5274002A (en) * 1987-04-14 1993-12-28 Warner-Lambert Company Trisubstituted phenyl analogs having activity for congestive heart failure
CA2015730C (en) * 1989-05-12 1997-10-07 Sadahiko Iguchi Esters of phenylalkanoic acid
US5232948A (en) * 1990-09-10 1993-08-03 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted monocyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
KR101695582B1 (ko) 2013-04-17 2017-01-13 화이자 인코포레이티드 심혈관 질환을 치료하기 위한 n-피페리딘-3-일벤즈아미드 유도체
EP3101303A4 (de) * 2014-01-29 2017-10-11 Sumitomo Bakelite Co.,Ltd. Bremsbelag- und sattelvorrichtung
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
MX2021008533A (es) 2019-01-18 2021-08-19 Astrazeneca Ab Inhibidores de la pcsk9 y metodos de uso de los mismos.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB673413A (en) * 1950-03-22 1952-06-04 Rhone Poulenc Sa New local anaesthetics which are substituted benzoic esters and processes for making the same
NL163775C (nl) * 1967-12-18 1980-10-15 Boehringer Sohn Ingelheim Werkwijze ter bereiding van farmaceutische preparaten met beta-receptoren blokkerende werking, alsmede werkwijze ter bereiding van 1-(cyaanfenoxy)-2-hydroxy-3-(sec.alkylamino) propaanderivaten.
GB1285038A (en) 1969-02-21 1972-08-09 Ici Ltd Alkanolamine derivatives
SE354851B (de) * 1970-02-18 1973-03-26 Haessle Ab
FR2132570B1 (de) 1971-04-09 1974-08-02 Lipha
PT66890B (fr) * 1976-08-21 1979-01-25 Hexachimie Procede pour la preparation des aryloxy-1 amino-3 propanol-2

Also Published As

Publication number Publication date
CS404781A2 (en) 1985-06-13
NO811799L (no) 1981-12-03
FI71725B (fi) 1986-10-31
FI71725C (fi) 1987-02-09
NZ197237A (en) 1985-01-31
FI811671L (fi) 1981-12-03
NO151282B (no) 1984-12-03
NO151282C (no) 1985-03-13
KR850000869B1 (ko) 1985-06-22
DK154208B (da) 1988-10-24
PT73111B (en) 1983-05-11
HU184860B (en) 1984-10-29
LU88348I2 (fr) 1994-09-09
AU548290B2 (en) 1985-12-05
IE53801B1 (en) 1989-03-01
NL930102I1 (nl) 1993-10-01
EP0041491B1 (de) 1985-01-30
ES8300679A1 (es) 1982-11-01
IE811217L (en) 1981-12-02
GR74571B (de) 1984-06-29
LU88317I2 (fr) 1994-05-04
DE3168595D1 (en) 1985-03-14
JPS5724335A (en) 1982-02-08
EP0041491A1 (de) 1981-12-09
ZA812981B (en) 1982-05-26
SU1156592A3 (ru) 1985-05-15
AU7116681A (en) 1982-12-02
DK239581A (da) 1981-12-03
DD159328A5 (de) 1983-03-02
PL135823B1 (en) 1985-12-31
SE8004087L (sv) 1981-12-03
DK154208C (da) 1989-03-20
CS241484B2 (en) 1986-03-13
PL231450A1 (en) 1983-03-28
JPS639501B2 (de) 1988-02-29
ES502656A0 (es) 1982-11-01
PT73111A (en) 1981-07-01
PH16135A (en) 1983-07-08
NL930102I2 (nl) 1994-12-01
KR830006177A (ko) 1983-09-20
MY8600219A (en) 1986-12-31

Similar Documents

Publication Publication Date Title
ATE11529T1 (de) Parasubstituierte 3-phenoxy-1-alkylaminopropan-2- ole mit beta-rezeptor blockierenden eigenschaften.
ATE12223T1 (de) Substituierte 3-phenoxy-1alkoxycarbonylalkylamino-propan-2-ole mit betarezeptor blockierenden eigenschaften.
FR2391215A1 (fr) Nouvelles imidazoazines et imidazodiazines, leur preparation et leur application en tant que medicaments
DE3362260D1 (en) (-)-15-deoxyspergualin, a process for the preparation of the same, and a pharmaceutical composition containing the same
FR2368489A1 (fr) Derives de la clavuline, leur procede de preparation et leur application en therapeutique

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time